| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |